Article info
PDFPaper
A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders
- Boadie W Dunlop, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1256 Briarcliff Road NE, Building A, 3rd Floor, Atlanta, GA 30322, USA; bdunlop{at}emory.edu
Citation
A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders
Publication history
- Received November 18, 2008
- Revised January 30, 2009
- Accepted March 3, 2009
- First published May 29, 2009.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group Ltd and the Institute of Medical Ethics
Other content recommended for you
- Ketamine for treatment-resistant depression: recent developments and clinical applications
- Empirical evidence against placebo controls
- Efficacy of repeated intravenous esketamine in adolescents with anxious versus non-anxious depression
- Stepped care for depression and anxiety in visually impaired older adults: multicentre randomised controlled trial
- Treatment of anxiety and depressive disorders in patients with cardiovascular disease
- Anxiety and depressive disorders are associated with delusional-like experiences: a replication study based on a National Survey of Mental Health and Wellbeing
- Migraine and its psychiatric comorbidities
- What proportion of initially prescribed antidepressants is still being prescribed chronically after 5 years in general practice? A longitudinal cohort analysis
- Randomised placebo-controlled trials of surgery: ethical analysis and guidelines
- Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit